As governments gathered for the UN CBD Working Group meeting in Granada in Jan 2006, indigenous peoples, farmers’ groups and NGOs renewed their calls for an international ban on ‘Terminator Technology’. […]
|
||||||
As governments gathered for the UN CBD Working Group meeting in Granada in Jan 2006, indigenous peoples, farmers’ groups and NGOs renewed their calls for an international ban on ‘Terminator Technology’. […] The latest round of UN talks held in Granada, Jan 2006 on an international agreement on access and benefit-sharing reflected the all-too-familiar tensions and conflicts between the developed and developing countries. […] A UN meeting held in Jan 2006 was an opportune occasion to revisit the difficult issues that states, indigenuous and local communities need to grapple with as they come to grips with the interplay of biodiversity and IPRs. […] This is an analysis on key decisions taken at the 3rd meeting of the Parties of the Cartagena Protocol on Biosafety which met from 13-17 March in Curitiba, Brazil. […] At the 3rd meeting of the Parties of the Cartagena Protocol on Biosafety in Brazil, agreement was finally reached on international documentation requirements for bulk shipments of genetically modified commodity grains. […] A website that publishes videos and information about the negotiations and side events at the 3rd Meeting of Parties of the Cartagena Protocol on Biosafety in Brazil. […] This is an assessment of the interim report of the WTO Panel considering the case “European Communities – Measures Affecting the Approval and Marketing of Biotech Products” which was made available to the parties in the dispute. […] Submission from South African Civil Societies to the Open-Ended Working Group of Legal and Technical Experts on Liability and Redress in the context of the Cartagena Protocol on Biosafety […] Submission from Third World Network to the Open-Ended Working Group of Legal and Technical Experts on Liability and Redress in the context of the Cartagena Protocol on Biosafety […] A proposal by a WHO advisory committee to preserve stocks of the smallpox virus in their laboratories for further research, including genetic engineering, was not approved by the World Health Assembly. […] |
||||||
All our content may be republished or reused for free, except where otherwise noted. This site is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License. Powered by WordPress & Atahualpa |